Lupin Digital Health has launched Vitalyfe, an AI-powered cardiometabolic wellness platform tailored for India’s corporate workforce. Built on its CDSCO-approved LYFE cardiac recovery system, Vitalyfe aims to deliver hospital-grade preventive care through insurers and employers, addressing rising heart health risks among professionals.
Platform Overview
Lupin Digital Health, the digital therapeutics arm of Lupin Ltd, has introduced Vitalyfe—a next-generation AI-powered platform focused on cardiometabolic wellness. Designed for working professionals, Vitalyfe integrates clinical science, behavioral insights, and artificial intelligence to offer personalized heart health programs. The platform builds on Lupin’s LYFE cardiac recovery system and extends its capabilities into preventive care, making it accessible through corporate partnerships, insurance providers, and brokers.
Major Takeaways
- Vitalyfe targets cardiometabolic risk management for India’s corporate population
- Built on Lupin’s LYFE platform, which is CDSCO-approved for cardiac recovery
- Offers hospital-grade care in a preventive wellness format
- Available via insurers, corporates, and brokers for employee health programs
- Uses AI and behavioral science to personalize interventions
Notable Updates
- Lupin Digital Health has doubled its patient base in the past year
- The company is expanding partnerships with hospitals and insurers
- Vitalyfe supports India’s growing demand for scalable, tech-enabled wellness solutions
Sources: Business Upturn, Lupin Digital Health, LDH Lyfe Platform